Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 7, 2022; 28(37): 5444-5456
Published online Oct 7, 2022. doi: 10.3748/wjg.v28.i37.5444
Published online Oct 7, 2022. doi: 10.3748/wjg.v28.i37.5444
OR | B coefficient | P value | 95%CI | |
LFN-COVID-19 index | 0.241 | -1.422 | 0.013 | 0.079-0.741 |
PaO2/FiO2 ratio | 1.000 | 0.000 | 0.877 | 0.996-1.004 |
Neutrophil/lymphocyte ratio | 1.043 | 0.042 | 0.030 | 1.004-1.083 |
Creatine phosphokinase | 1.001 | 0.001 | 0.340 | 0.999-1.002 |
Body mass index in kg/m2 | 1.093 | 0.089 | 0.002 | 1.033-1.157 |
- Citation: Macías-Rodríguez RU, Solís-Ortega AA, Ornelas-Arroyo VJ, Ruiz-Margáin A, González-Huezo MS, Urdiales-Morán NA, Román-Calleja BM, Mayorquín-Aguilar JM, González-Regueiro JA, Campos-Murguía A, Toledo-Coronado IV, Chapa-Ibargüengoitia M, Valencia-Peña B, Martínez-Cabrera CF, Flores-García NC. Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19. World J Gastroenterol 2022; 28(37): 5444-5456
- URL: https://www.wjgnet.com/1007-9327/full/v28/i37/5444.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i37.5444